log in
Back

WSG new york COVID-19 Resource Center

new york COVID-19 Resource Center

Around the Web


STATS
NEWS OUTLETS
News Feed Provided by Google News

new york
COVID-19 Task Force


Patterson Belknap Webb & Tyler LLP  

Legal Services | New York, USA

www.pbwt.com
tel: 212 336 2000 | fax: 212 336 2222
1133 Avenue of the Americas | New York | New York | 10036-6710 | USA

View Patterson Belknap Webb & Tyler's Task Force Hub Sort By Last Name  |  
Alejandro Cruz

Alejandro H. CruzPartner

  • Litigation
  • Privacy and Data Security

Jason Polevoy

Jason T. PolevoyCounsel

  • Real Estate


Daniel Lowenthal

Daniel A. LowenthalPartner

  • Business Reorganization and Creditors' Rights
  • Alternative Dispute Resolution

Catherine Williams

Catherine A. WilliamsPartner

  • Alternative Dispute Resolution
  • Complex Commercial Actions

Webinars & Podcasts


View All Upcoming North America Webinars | View All Webinars
Patterson Belknap Webb & Tyler Upcoming Webinars View All Firm Webinars

Latest Alerts


All new york COVID-19 articles | All Articles by Patterson Belknap Webb & Tyler

FDA Releases Industry Guidance on Development and Licensure of COVID-19 Vaccines
Patterson Belknap Webb & Tyler LLP, July 2020

The Food and Drug Administration (“FDA”) issued its Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry on June 30, 2020.  This nonbinding guidance is intended to remain in effect for the duration of the COVID-19 public health emergency declared by the Secretary of Health and Human Services...

read more

COVID-19 Update: IRS and DOL Extend COBRA and Other Benefit Plan Deadlines During the Pandemic Outbreak Period
Patterson Belknap Webb & Tyler LLP, May 2020

On April 28, 2020, the Employee Benefits Security Administration, the Department of Labor, the Internal Revenue Service, and the Department of the Treasury (the “Agencies”) signed a joint notification of relief, which was published in the Federal Register on May 4, 2020 (the “Notice”).1 The Notice provides extension of deadlines with respect to certain medical plan enrollments, election periods under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), COBRA premium payments, COBRA qualifying event notification periods, and certain plan claims, appeals and review periods...

read more

Cross-Border Tax-Related COVID-19 Relief
Patterson Belknap Webb & Tyler LLP, May 2020

On April 21, 2020, the IRS released a much-awaited package of guidance in the cross-border tax space that provides relief to those impacted by the COVID-19 pandemic. The guidance relates to (1) day-counting for both tax residency purposes and certain treaty positions, (2) the ability of taxpayers to claim the foreign-earned income exclusion, and (3) carrying on a U.S. trade or business. The summary below provides an overview of this guidance, which has been issued in a combination of IRS Revenue Procedures and a “Q&A” available on the IRS website. To continue reading our alert on this topic, please click here...

read more

EEOC Issues Guidance on the Permissibility of Mandatory COVID-19 Testing in the Workplace
Patterson Belknap Webb & Tyler LLP, May 2020

On April 23, 2020, the U.S. Equal Employment Opportunity Commission (“EEOC”) issued new guidance clarifying that employers may conduct mandatory testing of employees for COVID-19 before they enter the workplace so long as the testing is “job related and consistent with business necessity.”  The new guidance explains that employers may choose to test an employee for the virus before entering the workplace because an individual with COVID-19 will pose a direct threat to the health of others...

read more

The FDA Regulatory Landscape for COVID-19 Treatments and Vaccines
Patterson Belknap Webb & Tyler LLP, March 2020

As the United States and countries all over the world continue to grapple with the Covid-19 pandemic, the race is on for Covid-19 treatments and vaccines.  There is currently no FDA-approved therapy or vaccine for Covid-19.  Given the profound urgency, life sciences companies and other researchers are prioritizing research and development of potential therapies and vaccines...

read more

All new york COVID-19 articles | All Articles by Patterson Belknap Webb & Tyler

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2020